Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,593 High Cholesterol
clinical trials

Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Greenville, NC
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Hialeah, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Jackson, TN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Raleigh, NC
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Raleigh, NC
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Mineola, NY
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Nashville, TN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Greenville, SC
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Arlington, TX
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Charleston, SC
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Columbia, MD
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Erie, PA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Fleming Island, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Hartsdale, NY
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Knoxville, TN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Los Gatos, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Media, PA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Plano, TX
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Salisbury, NC
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Sayre, PA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
St. Paul, MN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Tucson, AZ
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Upland, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Valparaiso, IN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Warminster, PA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
West Hills, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Winchester, VA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology, Ophthalmology, Orthopedics / Podiatry Clinical Trial
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Status: Enrolling
Updated: 10/5/2015
mi
from
San Pedro, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Dietary Protein Sources and Atherogenic Dyslipidemia
Status: Enrolling
Updated: 8/3/2015
mi
from
Berkeley, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C
Status: Enrolling
Updated: 12/24/2013
mi
from
Nashville, TN
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Genetic Predictors of Outcome in HCM Patients
Status: Enrolling
Updated: 12/22/2015
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Status: Enrolling, Phase II
Updated: 10/5/2015
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Status: Enrolling, Phase II
Updated: 10/5/2015
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Status: Enrolling, Phase II
Updated: 10/5/2015
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Huntsville, AL
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Tampa, FL
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Troy, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Soda and Milk Study
Status: Enrolling
Updated: 8/3/2015
mi
from
Berkeley, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Richmond, VA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Rochester, NY
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Status: Enrolling, Phase II
Updated: 8/21/2015
mi
from
Louisville, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Stress and Sugar Synergy
Status: Enrolling
Updated: 12/3/2014
mi
from
Sacramento, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Short Term Intermittent Fasting and Mediterranean Diet
Status: Enrolling
Updated: 12/9/2015
mi
from
St Louis, MO
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Effects of Amino Acids on Regional Lipid Metabolism
Status: Enrolling
Updated: 1/6/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia
Status: Enrolling, Phase III
Updated: 2/19/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Nephrology / Urology Clinical Trial
Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome
Status: Enrolling, Phase I
Updated: 3/5/2016
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Layton, UT
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Portland, OR
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
San Diego, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Vista, CA
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/11/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/11/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Orthopedics / Podiatry, Other Clinical Trial
Fenofibrate Treatment in SCI
Status: Enrolling
Updated: 3/15/2016
mi
from
Bronx, NY
Click here to add this to my saved trials
Dyslipidemias Clinical Trial
A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia
Status: Enrolling, Phase I
Updated: 3/21/2016
mi
from
Marlton, NJ
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Tulsa, OK
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Aurora, CO
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Flint, MI
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Germantown, TN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Harleysville, PA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Miami, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Port Orange, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Port Orchard, WA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Sarasota, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Tampa, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Tucson, AZ
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Ventura, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Morristown, NJ
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
New York, NY
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Rochester, MN
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Akron, OH
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Atlantis, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Hialeah, FL
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 11 16